Mucus Relief Maximum Strength 1200 mg 1200 mg/1
Guaifenesin · TABLET, EXTENDED RELEASE · Guardian Drug Company
Mucus Relief Maximum Strength 1200 mg is a tablet, extended release containing guaifenesin at 1200 mg/1, taken oral. Manufactured by Guardian Drug Company.
Key Facts
- Brand Name
- Mucus Relief Maximum Strength 1200 mg
- Generic Name
- Guaifenesin
- NDC Code (Product)
53041-191- Manufacturer
- Guardian Drug Company
- Strength
- 1200 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA209215
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 06/24/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Mucus Relief Maximum Strength 1200 mg used for?
Mucus Relief Maximum Strength 1200 mg contains Guaifenesin. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Mucus Relief Maximum Strength 1200 mg a controlled substance?
Mucus Relief Maximum Strength 1200 mg is not classified as a controlled substance by the DEA.
What is the generic name for Mucus Relief Maximum Strength 1200 mg?
The generic name for Mucus Relief Maximum Strength 1200 mg is Guaifenesin. There are 12 other brand versions of Guaifenesin.
What is the NDC code for Mucus Relief Maximum Strength 1200 mg 1200 mg/1?
The NDC (National Drug Code) for Mucus Relief Maximum Strength 1200 mg 1200 mg/1 is 53041-191, listed by Guardian Drug Company.
Other Guaifenesin Brands
See all →- Guaifenesin and Dextromethorphan Hydrobromide10 mg/5mL72162-2277
- basic care mucus er600 mg/172288-298
- basic care mucus er max1200 mg/172288-613
- Pharbinex-DM20 mg/173057-381
- Mucus Relief DM Extended Release Caplets30 mg/10536-1161
- MUCUS RELIEF - DM MAXIMUM STRENGTH60 mg/173581-405
- BACZOL EXPECTORANT200 mg/5mL76864-209
- Guaifenesin and Pseudoephedrine HCl600 mg/179481-1002
- Meijer Adult Mucus Plus chest congestion200 mg/10mL79481-7430
- Tussin Mucus and Chest Congestion Sugar Free200 mg/10mL82568-0012
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)